Amgen’s MariTide Data Not The Hit Investors Sought

 
• By Joseph Haas
  
Close up of Amgen sign at its headquarters in Thousand Oaks, California, USA
Overall profile for Amgen's MariTide in obesity gets mixed reviews • Source: Shutterstock

More from Strategy

More from Therapy Areas